Alps Advisors Inc Danaher Corp Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$224.58 - $256.19 $216,719 - $247,223	-965 Reduced 3.89%	23,874 $5.96 Million
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $8,144 - $10,257	44 Added 0.18%	24,839 $5.75 Million
Q3 2023 Nov 14, 2023	BUY	$233.08 - $265.59 $4.71 Million - $5.37 Million	20,213 Added 441.14%	24,795 $6.15 Million
Q2 2023 Aug 14, 2023	SELL	$224.99 - $256.14 $1.11 Million - $1.26 Million	-4,930 Reduced 51.83%	4,582 $1.1 Million
Q1 2023 May 10, 2023	SELL	$239.75 - $277.0 $299,447 - $345,973	-1,249 Reduced 11.61%	9,512 $2.4 Million
Q4 2022 Feb 14, 2023	SELL	$241.42 - $282.29 $184,927 - $216,234	-766 Reduced 6.65%	10,761 $2.86 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $858,286 - $5.24 Million	3,474 Added 43.14%	11,527 $2.98 Million
Q2 2022 Aug 11, 2022	SELL	$237.11 - $299.66 $520,456 - $657,753	-2,195 Reduced 21.42%	8,053 $2.04 Million
Q1 2022 May 16, 2022	BUY	$257.27 - $315.76 $43,221 - $53,047	168 Added 1.67%	10,248 $3.01 Million
Q4 2021 Feb 09, 2022	SELL	$292.08 - $329.01 $66,594 - $75,014	-228 Reduced 2.21%	10,080 $3.32 Million
Q3 2021 Nov 15, 2021	SELL	$272.21 - $332.43 $160,331 - $195,801	-589 Reduced 5.41%	10,308 $3.14 Million
Q2 2021 Aug 11, 2021	BUY	$225.08 - $271.69 $50,643 - $61,130	225 Added 2.11%	10,897 $2.92 Million
Q1 2021 May 07, 2021	BUY	$212.38 - $245.9 $36,104 - $41,803	170 Added 1.62%	10,672 $2.4 Million
Q4 2020 Feb 03, 2021	SELL	$212.5 - $245.46 $434,987 - $502,456	-2,047 Reduced 16.31%	10,502 $2.33 Million
Q3 2020 Nov 05, 2020	SELL	$177.16 - $215.33 $405 Million - $493 Million	-2,287,330 Reduced 99.45%	12,549 $2.7 Million
Q3 2020 Nov 04, 2020	BUY	$177.16 - $215.33 $404 Million - $491 Million	2,280,278 Added 11633.48%	2,299,879 $747,000
Q2 2020 Aug 05, 2020	SELL	$128.7 - $176.83 $737,450 - $1.01 Million	-5,730 Reduced 22.62%	19,601 $3.47 Million
Q1 2020 May 06, 2020	SELL	$121.39 - $169.05 $1.04 Million - $1.45 Million	-8,574 Reduced 25.29%	25,331 $3.51 Million
Q4 2019 Feb 07, 2020	SELL	$133.47 - $153.48 $340,348 - $391,374	-2,550 Reduced 6.99%	33,905 $5.2 Million
Q3 2019 Nov 04, 2019	BUY	$135.4 - $146.47 $3.25 Million - $3.52 Million	24,012 Added 192.98%	36,455 $5.27 Million
Q2 2019 Aug 07, 2019	SELL	$124.88 - $143.73 $4.28 Million - $4.92 Million	-34,240 Reduced 73.35%	12,443 $1.78 Million
Q1 2019 May 01, 2019	SELL	$97.62 - $132.29 $720,142 - $975,903	-7,377 Reduced 13.65%	46,683 $6.16 Million
Q4 2018 Feb 04, 2019	SELL	$94.85 - $109.54 $979,326 - $1.13 Million	-10,325 Reduced 16.04%	54,060 $5.57 Million
Q3 2018 Oct 25, 2018	SELL	$98.13 - $108.9 $407,435 - $452,152	-4,152 Reduced 6.06%	64,385 $7 Million
Q2 2018 Jul 25, 2018	BUY	$96.1 - $103.24 $814,447 - $874,959	8,475 Added 14.11%	68,537 $6.76 Million
Q1 2018 May 01, 2018	BUY	$92.16 - $103.8 $1.36 Million - $1.54 Million	14,800 Added 32.7%	60,062 $5.88 Million
Q4 2017 Feb 05, 2018	BUY	$85.26 - $94.62 $34,274 - $38,037	402 Added 0.9%	45,262 $4.2 Million
Q3 2017 Nov 03, 2017	BUY	$79.29 - $88.45 $3.56 Million - $3.97 Million	44,860	44,860 $3.85 Million

Others Institutions Holding DHR

# of Institutions

2,510

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

Vanguard Group Inc Valley Forge, PA

59.4M
Shares

$14.1 Billion
0.3% of portfolio
Black Rock Inc. New York, NY

50.5M
Shares

$12 Billion
0.29% of portfolio
State Street Corp Boston, MA

27.5M
Shares

$6.53 Billion
0.32% of portfolio
Wellington Management Group LLP Boston, MA

23.3M
Shares

$5.54 Billion
1.16% of portfolio
Price T Rowe Associates Inc Baltimore, MD

20.5M
Shares

$4.87 Billion
0.66% of portfolio

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $173B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account